![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0251 SIRUKUMAB, an ANTI-IL-6 cytokine monoclonal antibody, leads to improvements in work productivity and general health status in patients with active rheumatoid arthritis refractory to ANTI-TNF therapy: results from the phase 3 SIRROUND-T study
Tanaka, Y, Aletaha, D, Peterson, S, Ganguly, R, Kurrasch, R, Popik, S, Agarwal, P, Li, NLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.3597
File:
PDF, 69 KB
english